MLL is a frequent target for recurrent translocations in acute leukemia cases, which can be classified as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or mixed lineage (biphenotypic) leukemia (MLL). This evidence concerns the gene KMT2A and acute myeloid leukemia.